Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
MLTX: MoonLake Immunotherapeutics Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
MLTX
The Story
MLTX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-75.3%
Financially safe
Stretched
Debt / equity
0.40×
Interest coverage
-28.1×
Current ratio
8.60×
MoonLake Immunotherapeutics
MLTX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
MoonLake Immunotherapeutics
MLTX
NASDAQ
·
USD
·
Closed
$18.44
−2.90%
$18.44
−$0.55 (2.90%)
52W Range
22th
pctl
Volume
0.70×
avg
Mkt Cap
1.55B
USD
P/E
-4.9
TTM
Div Yield
–
ann
52W Range
22th
pctl
Volume
0.70×
avg
Market Cap
1.55B
USD
P/E Ratio
-4.9
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings